Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Felix Y. Feng, MD"'
Autor:
Kevin Shee, MD, PhD, Claire M. de la Calle, MD, Albert J. Chang, MD, PhD, Anthony C. Wong, MD, PhD, Felix Y. Feng, MD, Alexander R. Gottschalk, MD, PhD, Peter R. Carroll, MD, MPH, Hao G. Nguyen, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 5, Pp 100941- (2022)
Background: Enzalutamide is an antiandrogen used to treat both metastatic and nonmetastatic prostate cancer. Here we present results from a phase 2 trial designed to determine the safety, tolerability, and efficacy of adding enzalutamide to standard
Externí odkaz:
https://doaj.org/article/ed25005708004bb9a4745b9b93ffa0b3
Autor:
William C. Jackson, MD, Felix Y. Feng, MD, Stephanie Daignault, PhD, Maha Hussain, MD, David Smith, MD, Kathleen Cooney, MD, Kenneth Pienta, MD, Shruti Jolly, MD, Brent Hollenbeck, MD, Karin B. Olson, PA-C, Howard M. Sandler, MD, Michael E. Ray, MD, PhD, Daniel A. Hamstra, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 1, Pp 59-66 (2016)
Purpose/Objective(s): We sought to assess the utility of docetaxel administered concurrently with salvage radiation therapy (SRT) following postprostatectomy biochemical failure (BF). Methods and materials: Men with postprostatectomy BF were accrued
Externí odkaz:
https://doaj.org/article/caf9011c751647a7ac6e69c0815d120f
Autor:
Sjöström M; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Fyles A; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Liu FF; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., McCready D; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Feng FY; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Speers CW; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Pierce LJ; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Holmberg E; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Fernö M; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Malmström P; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karlsson P; Martin Sjöström, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Anthony Fyles, MD; Fei-Fei Liu, MD; and David McCready, MD, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Felix Y. Feng, MD, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Corey W. Speers, MD, PhD and Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Erik Holmberg, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Mårten Fernö, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Per Malmström, MD, PhD, Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; and Per Karlsson, MD, PhD, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Aug 10; Vol. 41 (23), pp. 3959-3960. Date of Electronic Publication: 2023 Jun 06.
Autor:
Sperger JM; Jamie M. Sperger, PhD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI; Felix Y. Feng, MD, Helen Diller Family Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, UCSF, Department of Radiation Oncology, Department of Urology, University of California San Francisco, San Francisco, CA; Andrew J. Armstrong, MD, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC; Shuang G. Zhao, MD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Human Oncology, University of Wisconsin, Madison, WI, William S. Middleton Memorial Veterans Hospital, Madison, WI; and Joshua M. Lang, MD, MS, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Medicine, University of Wisconsin, Madison, WI., Feng FY; Jamie M. Sperger, PhD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI; Felix Y. Feng, MD, Helen Diller Family Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, UCSF, Department of Radiation Oncology, Department of Urology, University of California San Francisco, San Francisco, CA; Andrew J. Armstrong, MD, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC; Shuang G. Zhao, MD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Human Oncology, University of Wisconsin, Madison, WI, William S. Middleton Memorial Veterans Hospital, Madison, WI; and Joshua M. Lang, MD, MS, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Medicine, University of Wisconsin, Madison, WI., Armstrong AJ; Jamie M. Sperger, PhD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI; Felix Y. Feng, MD, Helen Diller Family Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, UCSF, Department of Radiation Oncology, Department of Urology, University of California San Francisco, San Francisco, CA; Andrew J. Armstrong, MD, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC; Shuang G. Zhao, MD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Human Oncology, University of Wisconsin, Madison, WI, William S. Middleton Memorial Veterans Hospital, Madison, WI; and Joshua M. Lang, MD, MS, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Medicine, University of Wisconsin, Madison, WI., Zhao SG; Jamie M. Sperger, PhD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI; Felix Y. Feng, MD, Helen Diller Family Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, UCSF, Department of Radiation Oncology, Department of Urology, University of California San Francisco, San Francisco, CA; Andrew J. Armstrong, MD, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC; Shuang G. Zhao, MD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Human Oncology, University of Wisconsin, Madison, WI, William S. Middleton Memorial Veterans Hospital, Madison, WI; and Joshua M. Lang, MD, MS, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Medicine, University of Wisconsin, Madison, WI., Lang JM; Jamie M. Sperger, PhD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI; Felix Y. Feng, MD, Helen Diller Family Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, UCSF, Department of Radiation Oncology, Department of Urology, University of California San Francisco, San Francisco, CA; Andrew J. Armstrong, MD, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC; Shuang G. Zhao, MD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Human Oncology, University of Wisconsin, Madison, WI, William S. Middleton Memorial Veterans Hospital, Madison, WI; and Joshua M. Lang, MD, MS, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Medicine, University of Wisconsin, Madison, WI.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Feb 10; Vol. 40 (5), pp. 520-522. Date of Electronic Publication: 2021 Dec 08.
Autor:
Rosenthal SA; Seth A. Rosenthal, MD, Sutter Medical Group and Sutter Cancer Centers, Sacramento, CA; Chen Hu, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Oliver Sartor, MD, Tulane University Health Services Center, New Orleans, LA; Felix Y. Feng, MD, University of California at San Francisco, San Francisco, CA; and Howard M. Sandler, MD, MS, Cedars-Sinai Medical Center, Los Angeles, CA., Hu C; Seth A. Rosenthal, MD, Sutter Medical Group and Sutter Cancer Centers, Sacramento, CA; Chen Hu, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Oliver Sartor, MD, Tulane University Health Services Center, New Orleans, LA; Felix Y. Feng, MD, University of California at San Francisco, San Francisco, CA; and Howard M. Sandler, MD, MS, Cedars-Sinai Medical Center, Los Angeles, CA., Sartor O; Seth A. Rosenthal, MD, Sutter Medical Group and Sutter Cancer Centers, Sacramento, CA; Chen Hu, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Oliver Sartor, MD, Tulane University Health Services Center, New Orleans, LA; Felix Y. Feng, MD, University of California at San Francisco, San Francisco, CA; and Howard M. Sandler, MD, MS, Cedars-Sinai Medical Center, Los Angeles, CA., Feng FY; Seth A. Rosenthal, MD, Sutter Medical Group and Sutter Cancer Centers, Sacramento, CA; Chen Hu, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Oliver Sartor, MD, Tulane University Health Services Center, New Orleans, LA; Felix Y. Feng, MD, University of California at San Francisco, San Francisco, CA; and Howard M. Sandler, MD, MS, Cedars-Sinai Medical Center, Los Angeles, CA., Sandler HM; Seth A. Rosenthal, MD, Sutter Medical Group and Sutter Cancer Centers, Sacramento, CA; Chen Hu, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Oliver Sartor, MD, Tulane University Health Services Center, New Orleans, LA; Felix Y. Feng, MD, University of California at San Francisco, San Francisco, CA; and Howard M. Sandler, MD, MS, Cedars-Sinai Medical Center, Los Angeles, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Sep 01; Vol. 37 (25), pp. 2297-2298. Date of Electronic Publication: 2019 Jul 01.
Autor:
Aggarwal R; Rahul Aggarwal, MD, University of California San Francisco, San Francisco, CA; Jiaoti Huang, MD, PhD, Duke University, Durham, NC; Joshi Alumkal, MD, Oregon Health Sciences University, Portland, OR; Felix Y. Feng, MD and Li Zhang, PhD, University of California San Francisco, San Francisco, CA; Joshua M. Stuart, PhD, University of California Santa Cruz, Santa Cruz, CA; and Eric J. Small, MD, University of California San Francisco, San Francisco, CA., Huang J; Rahul Aggarwal, MD, University of California San Francisco, San Francisco, CA; Jiaoti Huang, MD, PhD, Duke University, Durham, NC; Joshi Alumkal, MD, Oregon Health Sciences University, Portland, OR; Felix Y. Feng, MD and Li Zhang, PhD, University of California San Francisco, San Francisco, CA; Joshua M. Stuart, PhD, University of California Santa Cruz, Santa Cruz, CA; and Eric J. Small, MD, University of California San Francisco, San Francisco, CA., Alumkal J; Rahul Aggarwal, MD, University of California San Francisco, San Francisco, CA; Jiaoti Huang, MD, PhD, Duke University, Durham, NC; Joshi Alumkal, MD, Oregon Health Sciences University, Portland, OR; Felix Y. Feng, MD and Li Zhang, PhD, University of California San Francisco, San Francisco, CA; Joshua M. Stuart, PhD, University of California Santa Cruz, Santa Cruz, CA; and Eric J. Small, MD, University of California San Francisco, San Francisco, CA., Feng FY; Rahul Aggarwal, MD, University of California San Francisco, San Francisco, CA; Jiaoti Huang, MD, PhD, Duke University, Durham, NC; Joshi Alumkal, MD, Oregon Health Sciences University, Portland, OR; Felix Y. Feng, MD and Li Zhang, PhD, University of California San Francisco, San Francisco, CA; Joshua M. Stuart, PhD, University of California Santa Cruz, Santa Cruz, CA; and Eric J. Small, MD, University of California San Francisco, San Francisco, CA., Zhang L; Rahul Aggarwal, MD, University of California San Francisco, San Francisco, CA; Jiaoti Huang, MD, PhD, Duke University, Durham, NC; Joshi Alumkal, MD, Oregon Health Sciences University, Portland, OR; Felix Y. Feng, MD and Li Zhang, PhD, University of California San Francisco, San Francisco, CA; Joshua M. Stuart, PhD, University of California Santa Cruz, Santa Cruz, CA; and Eric J. Small, MD, University of California San Francisco, San Francisco, CA., Stuart JM; Rahul Aggarwal, MD, University of California San Francisco, San Francisco, CA; Jiaoti Huang, MD, PhD, Duke University, Durham, NC; Joshi Alumkal, MD, Oregon Health Sciences University, Portland, OR; Felix Y. Feng, MD and Li Zhang, PhD, University of California San Francisco, San Francisco, CA; Joshua M. Stuart, PhD, University of California Santa Cruz, Santa Cruz, CA; and Eric J. Small, MD, University of California San Francisco, San Francisco, CA., Small EJ; Rahul Aggarwal, MD, University of California San Francisco, San Francisco, CA; Jiaoti Huang, MD, PhD, Duke University, Durham, NC; Joshi Alumkal, MD, Oregon Health Sciences University, Portland, OR; Felix Y. Feng, MD and Li Zhang, PhD, University of California San Francisco, San Francisco, CA; Joshua M. Stuart, PhD, University of California Santa Cruz, Santa Cruz, CA; and Eric J. Small, MD, University of California San Francisco, San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Feb 01; Vol. 37 (4), pp. 351-352. Date of Electronic Publication: 2018 Dec 17.